Nonadherence to Cancer Screening Varies by Screening Type
Life dissatisfaction linked to nonadherence for cervical cancer and breast cancer screenings
Risk for Device Failure Similar With Different PICC Materials
Risk for device failure was not significantly different with hydrophobic or chlorhexidine PICCs versus standard polyurethane PICCs
Talquetamab Plus Teclistamab Shows Promise in Multiple Myeloma
Grade 3 or 4 adverse events occurred in 96 percent of patients; grade 3 or 4 infections occurred in 64 percent
Physical Activity May Improve Outcomes in People Diagnosed With Cancer
Dose-response relationship seen between physical activity and lower rates of cancer progression, all-cause mortality
Position Statement Developed for Managing Blood Cancers in Pregnancy
Multidisciplinary collaborative approach to care is required for patients with hematological malignancies in pregnancy
Surgeon General Highlights Link Between Alcohol and Cancer, Urges Warning Labels
Evidence linking alcohol to cancer has accumulated for years, yet less than half of Americans recognize it as a cancer risk factor
Decrease Seen in In Situ Breast Cancer Since 2009
Decrease consistent with decreasing use of screening mammography since 2009 guideline change
Six-Month Mortality Lower With Liberal Transfusion Strategy in Acute MI With Anemia
No significant difference seen in composite of 30-day mortality or MI; cardiac death at 30 days increased with restrictive strategy
Individuals With Advanced Breast Cancer at Diagnosis More Likely to Have CVD
For female patients aged at least 66 years, odds of prevalent CVD up with locally advanced and metastatic disease
FDA Approves Subcutaneous Opdivo Qvantig for Most Solid Tumor Indications
Approval based on noninferior pharmacokinetic exposures, similar effectiveness and safety to intravenous Opdivo
